These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 65215)

  • 1. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
    Günther J
    Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
    Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
    Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
    Rahi AH; Otiko G; Winder AF
    Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross-reactivity of 3M KCl extracts of fetal tissue from various species in the macrophage electrophoresis mobility (MEM) test. I. Extracts from fetuses of mammals and one species of fowl].
    Schlott B; Gryschek G; Reinhöfer J; von Broen B; Pasternak G
    Arch Geschwulstforsch; 1983; 53(2):93-8. PubMed ID: 6344836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
    Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
    Oncology; 1978; 35(4):163-7. PubMed ID: 81476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
    Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
    Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.
    Steinman L; Cohen IR; Teitelbaum D; Arnon R
    Nature; 1977 Jan; 265(5590):173-5. PubMed ID: 64932
    [No Abstract]   [Full Text] [Related]  

  • 20. A reappraisal of the macrophage electrophoretic mobility (MEM) test for the measurement of lymphokine activity.
    Brown KA; Wolstencroft RA; Booth CG; Dumonde DC
    J Immunol Methods; 1985 Oct; 82(2):189-98. PubMed ID: 3900214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.